Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AMGEN INC. Hits Price Target Forecast with 13.59% Profit Achieved

January 02, 2024

The forecast signal for AMGEN INC. was issued on August 15, 2023, with a price of 247.88 $. The prediction indicated a long position, and on January 2, 2024, the target price of 281.56 $ was reached, resulting in a profit of 13.59%. This successful forecast demonstrates the accuracy of QuantWave's analytics in predicting stock movements.

Market analysis suggests that AMGEN INC.'s performance was influenced by positive developments in its drug pipeline, particularly in the area of biotechnology. The company's strong financials and strategic acquisitions also contributed to investor confidence, driving the stock price higher.

QuantWave's achievement of its price target forecast for AMGEN INC. showcases the platform's ability to provide valuable insights for investors seeking profitable opportunities in the market. By leveraging QuantWave's automated forecasting capabilities, users can access predictions for a wide range of stocks, opening up possibilities for generating returns on their investments.

For those interested in delving deeper into QuantWave's investment strategy, QuantSchool offers comprehensive educational resources that outline the key principles for utilizing the forecasting system effectively. By following the guidelines provided by QuantSchool, investors can enhance their understanding of the market and optimize their investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


VRTXJanuary 6, 2025Investors Should Consider Buying Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Now  ~2 min.

Vertex Pharmaceuticals Incorporated is a leading biotechnology company specializing in the discovery, development, and commercialization of innovative medicines for serious diseases....


REGNJanuary 4, 2025Regeneron Pharmaceuticals Inc.: A Strong Investment Opportunity for Shareholders  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has proven to be a successful investment option for shareholders, with a decent 89% return over the last five years....


REGNFebruary 3, 2025Regeneron Pharmaceuticals Inc. Receives Positive Analyst Recommendations  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) has recently received bullish recommendations from leading analysts, indicating a positive outlook for the company's future....


BIIBOctober 8, 2024Biogen Inc. Stock Hits Price Target Forecast with 9.14% Profit: A Success Story for QuantWave  ~2 min.

Biogen Inc., a leading biotechnology company, saw its stock price hit the forecasted target with a profit of 9.14% in a short position signaled by QuantWave on September 10, 2024, at a price of 200.64$....


BIIBFebruary 4, 2025Biogen Inc. Sees Optimistic Outlook as Analysts Share Positive Views  ~2 min.

Biogen Inc., a leading biotechnology company, is generating significant interest among analysts as its stock continues to garner attention....